Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide
- PMID: 11243864
- DOI: 10.1006/bbrc.2001.4521
Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide
Abstract
We have previously demonstrated that the activation of p53 signaling may contribute to tumor growth inhibition by the CRE-decoy oligonucleotide containing CRE sequence (5'-TGACGTCA-3') (Lee et al., Biochemistry 39, 4863-4868, 2000). However, growth inhibition by CRE-decoy treatment was also observed in tumor cells containing a mutant p53 (Park et al., J. Biol. Chem. 274, 1573-1580, 1999). To understand additional mechanisms of the decoy oligonucleotide, we investigated the effect on cyclin D1 expression and a cyclin D1/Cdk4/retinoblastoma protein (pRB) signaling pathway. Here we show that in MCF7 breast cancer cells the CRE-decoy competed with cyclin D1-CRE (5'-TAACGTCA-3') for binding transcription factors and reduced cyclin D1 gene expression (in reporter gene assay, Northern blotting and Western blotting) to modulate cyclin D1/Cdk4/pRB signaling and G1-S progression in a steady state and/or under estrogen stimulation. Decrease of cyclin D1 protein level by CRE-decoy treatment was also observed in p53-mutated cancer cells. Cyclin D1 expression was also diminished in MCF7 cells stably expressing dominant negative mutant CREB indicating that the nonspecific effect of oligonucleotide or its degradation products could be excluded. These data suggest that inhibition of cyclin D1 expression contributes to the growth inhibition induced by the decoy oligonucleotide in MCF7 cells through a cyclin D1/Cdk4/pRB signaling pathway. Downregulation of cyclin D1 expression also provides a mechanism of CRE-decoy-induced growth inhibition in tumor cells having p53 mutation.
Copyright 2001 Academic Press.
Similar articles
-
CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.Biochemistry. 2000 Apr 25;39(16):4863-8. doi: 10.1021/bi992272o. Biochemistry. 2000. PMID: 10769144
-
pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.Oncogene. 2000 Aug 17;19(35):4035-41. doi: 10.1038/sj.onc.1203743. Oncogene. 2000. PMID: 10962560
-
Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.Mol Cell Biol Res Commun. 2000 Jun;3(6):352-9. doi: 10.1006/mcbr.2000.0238. Mol Cell Biol Res Commun. 2000. PMID: 11032757
-
Examining the role of cyclin D1 in breast cancer.Future Oncol. 2011 Jun;7(6):753-65. doi: 10.2217/fon.11.56. Future Oncol. 2011. PMID: 21675838 Review.
-
CRE-decoy oligonucleotide-inhibition of gene expression and tumor growth.Mol Cell Biochem. 2000 Sep;212(1-2):29-34. Mol Cell Biochem. 2000. PMID: 11108133 Review.
Cited by
-
Investigation of Key Signaling Pathways Associating miR-204 and Common Retinopathies.Biomed Res Int. 2021 Oct 4;2021:5568113. doi: 10.1155/2021/5568113. eCollection 2021. Biomed Res Int. 2021. PMID: 34646884 Free PMC article.
-
Artemether suppresses cell proliferation and induces apoptosis in diffuse large B cell lymphoma cells.Exp Ther Med. 2017 Nov;14(5):4083-4090. doi: 10.3892/etm.2017.5063. Epub 2017 Aug 29. Exp Ther Med. 2017. PMID: 29104626 Free PMC article.
-
Cyclic AMP-response element regulated cell cycle arrests in cancer cells.PLoS One. 2013 Jun 28;8(6):e65661. doi: 10.1371/journal.pone.0065661. Print 2013. PLoS One. 2013. PMID: 23840351 Free PMC article.
-
A genomic-scale view of the cAMP response element-enhancer decoy: a tumor target-based genetic tool.Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15626-31. doi: 10.1073/pnas.242617799. Epub 2002 Nov 18. Proc Natl Acad Sci U S A. 2002. PMID: 12438686 Free PMC article.
-
Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo.J Neurosci. 2001 Dec 1;21(23):9204-13. doi: 10.1523/JNEUROSCI.21-23-09204.2001. J Neurosci. 2001. PMID: 11717354 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous